DCMIC
ATRC icon

Decheng Capital Management III (Cayman)’s AtriCure ATRC Stock Holding History

Decheng Capital Management III (Cayman)’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$2.03M Buy
+46,259
New +$2.26M 0.68% 21
2023
Q2 		– Sell
-46,259
Closed -$1.92M – 26
2023
Q1 		$1.92M Buy
+46,259
New +$1.92M 0.77% 19

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Decheng Capital Management III (Cayman)'s ATRC Position: Q3 2023 in Review

Decheng Capital Management III (Cayman) opened a new position in AtriCure (ATRC) in Q3 2023: 46,259 shares worth $2.03M. The stake represents 0.68% of the portfolio and ranks #21 among its holdings. This is a return to the name: Decheng Capital Management III (Cayman) previously reported a position in ATRC as recently as Q1 2023.

Decheng Capital Management III (Cayman) first reported a position in ATRC in Q1 2023 and has held it in 2 quarters since. 230 funds tracked by Wall St. Rank hold ATRC as of Q3 2023.

  • Decheng Capital Management III (Cayman) held 46,259 shares of AtriCure worth $2.03M as of Q3 2023.
  • AtriCure was a new Decheng Capital Management III (Cayman) position in Q3 2023.
  • AtriCure made up 0.68% of Decheng Capital Management III (Cayman)'s portfolio in Q3 2023, its #21 holding.
  • Decheng Capital Management III (Cayman) first reported a position in AtriCure in Q1 2023 and has held it in 2 quarters since.
  • 230 funds tracked by Wall St. Rank held AtriCure as of Q3 2023.

Based on Decheng Capital Management III (Cayman)'s 13F filing for Q3 2023, filed 13 Nov 2023.